Form 483

Adnan M. Dahdul, M.D. Form 483, 2024-06-20

FDA issued a Form 483 to Adnan M. Dahdul, M.D. on 2024-06-20 with 3 public-safe observations.

483· Form 483 issuedBiologics3 observations

Adnan M. Dahdul, M.D. · Springfield, United States · Issued June 20, 2024

Overview

  • 3 public-safe observations are available for this inspection.
  • 3 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

20 Jun 2024
21 CFR 312.60

FD-1572, protocol compliance

Cited by Matthew C Watson, Asia D Clark

20 Jun 2024
21 CFR 312.62(b)

Case history records- inadequate or inadequate

Cited by Matthew C Watson, Asia D Clark

20 Jun 2024
21 CFR 50.20

Consent not obtained, exceptions do not apply

Cited by Matthew C Watson, Asia D Clark

Inspected site

AMAdnan M. Dahdul, M.D.Springfield, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 312.60Cited across public-safe Form 483 observations1x
21 CFR 312.62(b)Cited across public-safe Form 483 observations1x
21 CFR 50.20Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 3 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere